Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleGP‐2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP‐Kinase and impairs the NF‐kB pathway in pancreatic cancer cells.AuthorsMajchrzak‐Stiller, Britta; Buchholz, Marie; Peters, Ilka; Waschestjuk, Daniel; Strotmann, Johanna; Höhn, Philipp; Hahn, Stephan; Braumann, Chris; Uhl, Waldemar; Müller, Thomas; Möhler, HannsPublicationJournal of Cellular & Molecular Medicine, 2023, Vol 27, Issue 14, p2082ISSN1582-1838Publication typeArticleDOI10.1111/jcmm.17825